CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-14 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −4,168 | $0.83 | $3K | 53,079 |
| 2020-06-14 | Paggiarino Dario A. Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −14,200 | 14,200 | ||
| 2020-03-12 | Elston George Chief Financial Officer | Purchase | +10,000 | $0.96 | $10K | 20,000 |
| 2020-03-10 | Lurker Nancy President & CEO | Purchase | +98,000 | $1.06 | $104K | 574,800 |
| 2020-02-28 | Mazzo David J Director | Grant or award · Restricted Stock Units | +19,000 | 19,000 | ||
| 2020-02-28 | Mazzo David J Director | Grant or award · Stock Option (Right to Buy) | +33,500 | 33,500 | ||
| 2020-02-28 | GUYER DAVID R Director | Grant or award · Restricted Stock Units | +19,000 | 19,000 | ||
| 2020-02-28 | GUYER DAVID R Director | Grant or award · Stock Option (Right to Buy) | +33,500 | 33,500 | ||
| 2020-02-28 | Peterson Kristine Director | Grant or award · Restricted Stock Units | +19,000 | 19,000 | ||
| 2020-02-28 | Peterson Kristine Director | Grant or award · Stock Option (Right to Buy) | +33,500 | 33,500 | ||
| 2020-02-28 | Godshall Douglas Evan Director | Grant or award · Restricted Stock Units | +19,000 | 19,000 | ||
| 2020-02-28 | Godshall Douglas Evan Director | Grant or award · Stock Option (Right to Buy) | +33,500 | 33,500 | ||
| 2020-02-28 | Elston George Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +110,371 | 110,371 | ||
| 2020-02-28 | Duker Jay S. Director | Grant or award · Restricted Stock Units | +19,000 | 19,000 | ||
| 2020-02-28 | Duker Jay S. Director | Grant or award · Stock Option (Right to Buy) | +33,500 | 33,500 | ||
| 2020-02-28 | DICICCO WENDY F Director | Grant or award · Restricted Stock Units | +19,000 | 19,000 | ||
| 2020-02-28 | DICICCO WENDY F Director | Grant or award · Stock Option (Right to Buy) | +33,500 | 33,500 | ||
| 2020-02-28 | Landis John B. Director | Grant or award · Restricted Stock Units | +19,000 | 19,000 | ||
| 2020-02-28 | Landis John B. Director | Grant or award · Stock Option (Right to Buy) | +33,500 | 33,500 | ||
| 2020-02-28 | ANDO GORAN Director | Grant or award · Restricted Stock Units | +21,500 | 21,500 |
Page 33 of 40 · 795 trades